Enveric Biosciences (ENVB) Total Debt (QoQ) (2015 - 2020)
Enveric Biosciences (ENVB) Total Debt (QoQ) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Enveric Biosciences | 5.42 Mn | -2.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -24.55% |
| Jun 30, 2020 | -45.38% |
| Mar 31, 2020 | 20,219.93% |
| Dec 31, 2019 | -99.35% |
| Mar 31, 2019 | 64,820.29% |
| Dec 31, 2018 | -99.82% |
| Sep 30, 2018 | 10.18% |
| Jun 30, 2018 | -23.84% |
| Mar 31, 2018 | -17.17% |
| Dec 31, 2017 | 161.63% |
| Sep 30, 2017 | 13.89% |
| Jun 30, 2017 | -65.07% |
| Mar 31, 2017 | 7.67% |
| Dec 31, 2016 | 195.22% |
| Sep 30, 2016 | -71.52% |
| Jun 30, 2016 | 1,000.00% |
| Mar 31, 2016 | -91.98% |
| Dec 31, 2015 | 2,394.37% |